Secondary amyloidosis in three patients with ankylosing spondylitis responded well to etanercept

Basit Öğe Kaydı
dc.contributor.authorKobak, S.
dc.contributor.authorOksel, F.
dc.date.accessioned2019-10-27T19:33:28Z
dc.date.available2019-10-27T19:33:28Z
dc.date.issued2007
dc.departmentEge Üniversitesien_US
dc.descriptionAnnual European Congress of Rheumatology (EULAR 2007) -- JUN 13-16, 2007 -- Barcelona, SPAINen_US
dc.description.sponsorshipEuropean League Against Rheumatismen_US
dc.identifier.endpage402en_US
dc.identifier.issn0003-4967
dc.identifier.startpage402en_US
dc.identifier.urihttps://hdl.handle.net/11454/39478
dc.identifier.volume66en_US
dc.identifier.wosWOS:000253101101575en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherB M J Publishing Groupen_US
dc.relation.ispartofAnnals of the Rheumatic Diseasesen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSecondary amyloidosis in three patients with ankylosing spondylitis responded well to etanercepten_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu